Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Avastin bevacizumab: Phase II data

In an open-label Phase II trial in 167 patients with relapsed GBM, 6-month PFS was

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE